Tag Archives: Federal Circuit

Myriad vs. Mayo – Detection vs. Processing at the Fed. Cir.

Posted on April 26, 2016 by Warren Woessner

Rapid Litigation Mgmt v. CellzDirect: Splitting Detection of a Natural Phenomenon from its Application to Yield a Product. Courtenay G. Brinkerhoff at pharmapatentsblog.com summarized the oral arguments at the Fed. Cir. (App. No. 15-1570) conducted on April 5, 2016 in … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | 1 Comment

Genetic Technologies Affirms Ariosa/Myriad With An Introduction By The Sequenom Petition for Cert.

Posted on April 11, 2016 by Warren Woessner

On April 1st, Lilly filed an amicus brief in favor of Sequenom’s petition for cert. seeking to reverse Ariosa, that caused a lot of buzz in the IP community. (A copy is available at the end of this post.) To … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | 1 Comment

Happy Birthday to Us! We are 7 Years Old!

Posted on April 4, 2016 by Warren Woessner

In fact, Patents4Life’s birthday was in late March of 2009, but the earliest posts were short papers I wrote for an IP newsletter that no longer exists. However, the s. 101 storm clouds were gathering even then. One article (in … Continue reading →

Posted in Miscellaneous | Tagged , , , , , , , | 2 Comments

Superman Breyer v. Batman Lourie Battle in the Sequenom Petition for Cert.

Posted on March 27, 2016 by Warren Woessner

Since this is an amplification of my last post on the Sequenom petition for cert. in Sequenom v. Ariosa, please go back at read my first post on the petition. I have been arguing for some years that the patent … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment